Wird geladen...
Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?
We report a young male patient who developed plasma cell myeloma/plasmacytoma 11 years after having received an allogeneic hematopoietic cell transplantation for AML. The patient received a second transplantation from the same donor without immunosuppression and developed graft-versus-host disease (...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
Hindawi Publishing Corporation
2012
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3395258/ https://ncbi.nlm.nih.gov/pubmed/22811719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/319530 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|